Topics

Brain structural correlates of alexithymia in patients with major depressive disorder

08:00 EDT 11th October 2019 | BioPortfolio

Summary of "Brain structural correlates of alexithymia in patients with major depressive disorder"

Alexithymia is a risk factor for major depressive disorder (MDD) and has been associated with diminished treatment response. Neuroimaging studies have revealed structural aberrations of the anterior cingulate cortex and the fusiform gyrus in healthy controls with high levels of alexithymia. The present study tried to corroborate and extend these results to patients with MDD compared with healthy controls.

Affiliation

Journal Details

This article was published in the following journal.

Name: Journal of psychiatry & neuroscience : JPN
ISSN: 1488-2434
Pages: 190044

Links

DeepDyve research library

PubMed Articles [39838 Associated PubMed Articles listed on BioPortfolio]

Structural alterations of the brain preceded functional alterations in major depressive disorder patients: Evidence from multimodal connectivity.

Recent studies showed that major depressive disorder (MDD) has been involved in abnormal functional and structural connections in specific brain regions. However, comprehensive researches on MDD-relat...

Hippocampus-driving progressive structural alterations in medication-naïve major depressive disorder.

Major depressive disorder (MDD) is associated with abnormalities in brain structure. However, structural abnormality findings have been inconsistent and how structural changes lead to progressive morp...

Brain structural abnormalities in emotional regulation and sensory processing regions associated with anxious depression.

Considerable patients with major depressive disorder (MDD) comorbid with anxious symptoms, referred as anxious depression. The neural structural basis of this MDD specifier remains largely unknown.

Altered Brain Entropy as a predictor of antidepressant response in major depressive disorder.

To explore the alterations and value of brain entropy (BEN) in major depressive disorder (MDD).

Prevalence of major depressive disorder and its socio-demographic correlates in the general adult population in Hebei province, China.

Major depressive disorder (MDD) is a common psychiatric disorder which is associated with significant disability and psychosocial factors. There are only few epidemiological studies of MDD in economic...

Clinical Trials [9887 Associated Clinical Trials listed on BioPortfolio]

Brain Imaging of Psychotherapy for Depression

The goal of the proposed research is to examine the neural correlates of depressive symptom reduction in individuals with major depressive disorder using functional magnetic resonance imag...

Alexithymia Frequency and Interhemispheric Transfer in Patients With a First Demyelinating Event

Prevalence of alexithymia in multiple sclerosis (MS) is closed to 50% but is unknown in clinically isolated syndrome (CIS).The present study sought to characterize alexithymia in CIS patie...

Brain Changes in Severely Depressed Patients Before and After Treatment With Electroconvulsive Therapy

Electroconvulsive therapy (ECT) is a non-pharmacological treatment used in resistant depression whose effectiveness has been demonstrated. However, the brain mechanisms underlying this the...

Structural Brain Abnormalities in Children Born Prematurely: New Detection Methods and Clinical-Pathological Correlates

The purpose of the study is to detect structural brain changes using MRI and to correlate these findings with neurodevelopmental assessments in two-year old children previously enrolled in...

Neurobiological, Neuropsychological,Linguistic and Gestural Processes and Phenomena in Individuals With Alexithymia

The syndrome of extremely restricted emotional competence, alexithymia, was originally conceptualized in psychoanalytic research and is now empirically and experimentally studied in clinic...

Medical and Biotech [MESH] Definitions

A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)

A family of predominantly nuclear proteins that regulate gene transcription and protein degradation. The expansion of CAG trinucleotide repeats in genes that encode Ataxins is associated with SPINOCEREBELLAR ATAXIAS (SCA). In SCA patients, the number of CAG repeats correlates with the severity of disease and inversely correlates with the age of disease onset.

A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.

Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.

Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.

Quick Search


DeepDyve research library

Searches Linking to this Article